Gene expression profiles in Parkinson disease prefrontal cortex implicate FOXO1 and genes under its transcriptional regulation.
Parkinson disease (PD) is a complex neurodegenerative disorder with largely unknown genetic mechanisms. While the degeneration of dopaminergic neurons in PD mainly takes place in the substantia nigra pars compacta (SN) region, other brain areas, including the prefrontal cortex, develop Lewy bodies,...
Main Authors: | Alexandra Dumitriu, Jeanne C Latourelle, Tiffany C Hadzi, Nathan Pankratz, Dan Garza, John P Miller, Jeffery M Vance, Tatiana Foroud, Thomas G Beach, Richard H Myers |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-06-01
|
Series: | PLoS Genetics |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22761592/pdf/?tool=EBI |
Similar Items
-
microRNA profiles in Parkinson’s disease prefrontal cortex
by: Andrew G Hoss, et al.
Published: (2016-03-01) -
Evaluation of Parkinson disease risk variants as expression-QTLs.
by: Jeanne C Latourelle, et al.
Published: (2012-01-01) -
The 4p16.3 Parkinson Disease Risk Locus Is Associated with GAK Expression and Genes Involved with the Synaptic Vesicle Membrane.
by: Michael W Nagle, et al.
Published: (2016-01-01) -
Genes regulated in MPTP-treated macaques and human Parkinson's disease suggest a common signature in prefrontal cortex
by: Markus Storvik, et al.
Published: (2010-06-01) -
Neuropathology in the dorsolateral prefrontal cortex in Parkinson's disease
by: Lanoue, Amelie Cecile
Published: (2015)